Literature DB >> 24709945

Osteoarthritis: Repositioning verapamil--for Wnt of an OA treatment.

Nicholas J Bernard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24709945     DOI： 10.1038/nrrheum.2014.60

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Verapamil protects against cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling.

Authors:  Akira Takamatsu; Bisei Ohkawara; Mikako Ito; Akio Masuda; Tadahiro Sakai; Naoki Ishiguro; Kinji Ohno
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240
  1 in total
  3 in total

1.  Sirt1 regulates apoptosis and extracellular matrix degradation in resveratrol-treated osteoarthritis chondrocytes via the Wnt/β-catenin signaling pathways.

Authors:  Shuan Liu; Hongping Yang; Bing Hu; Mingyong Zhang
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

2.  Repositioning again of zonisamide for nerve regeneration.

Authors:  Kinji Ohno; Hideki Yagi; Bisei Ohkawara
Journal:  Neural Regen Res       Date:  2016-04       Impact factor: 5.135

3.  The β-catenin/TCF-4 pathway regulates the expression of OPN in human osteoarthritic chondrocytes.

Authors:  Jian Tian; Shu-Guang Gao; Yu-Sheng Li; Chao Cheng; Zhen-Han Deng; Wei Luo; Fang-Jie Zhang
Journal:  J Orthop Surg Res       Date:  2020-08-20       Impact factor: 2.359
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.